|
Nov 29
|
Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023
|
|
Sep 6
|
Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD
|
|
Jul 18
|
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology
|
|
Mar 8
|
We're A Little Worried About Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate
|
|
Mar 7
|
The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
|
|
Mar 6
|
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
|